Interest of Virtual Reality in the Management of Anxiety and Pain During Embryo Transfer (ET) (NCT05925400) | Clinical Trial Compass
TerminatedNot Applicable
Interest of Virtual Reality in the Management of Anxiety and Pain During Embryo Transfer (ET)
Stopped: Insufficient enrollment rate
France12 participantsStarted 2023-11-15
Plain-language summary
This study compares the use of virtual Reality versus the usual service protocol for the management of anxiety and pain related to In-Vitro fertilization (IVF) procedure
Who can participate
Age range18 Years – 43 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Will benefit from in vitro Fertilization (IVF or ICSI)
* Aged over 18 and under 43,
* Attempt Rank 1 or 2
* Requiring a transfer of a single fresh blastocyst on the 5th day of development OR a frozen embryo on the 5th day of development
* Having received information and given their consent to participate in accordance with the regulations
* Benefiting from a social security scheme or entitled.
Exclusion Criteria:
* Use of frozen sperm
* Use of testicular sperm
* Fecundation technique used: IMSI
* Early embryo transfer on D2 or D3
* Inability to understand the information given
* Under guardianship, under curatorship or under safeguard of justice,
* Communication difficulties or neuropsychic disorders,
* Current corneal or conjunctival pathologies,
* Claustrophobia,
* Appearance of nausea in the mountains or at sea,
* Regular use of anxiolytics
What they're measuring
1
Clinical Pregnancy Rate
Timeframe: Assessed 12 weeks after embryo transfer